DERIVES DE 2,3-DIHYDRO-4 H-1,3-BENZOXAZIN-4-ONE COMME MODULATEURS DU RECEPTEUR M1 MUSCARINIQUE CHOLINERGIQUE

• 收藏
• 分享

专利权人:

TAKEDA PHARMACEUTICAL COMPANY LIMITED

发明人:

SUGIMOTO, TAKAHIRO,SUZUKI, SHINKICHI,SAKAMOTO, HIROKI,YAMADA, MASAMI,NAKAMURA, MINORU,KAMATA, MAKOTO,SHIMOKAWA, KENICHIRO,OGINO, MASAKI,KIMURA, EIJI,MURAKAMI, MASATAKA,YONEMORI, JINICHI,KOJIMA, TAKUTO

申请号：

CA2988572

公开号：

CA2988572A1

申请日:

2016.06.23

申请国别(地区):

CA

年份:

2016

代理人:

摘要：

The present invention provides a compound having a cholinergic muscarinic M1 receptor positive allosteric modulator activity, which may be useful as a prophylactic or therapeutic drug for Alzheimer's disease, schizophrenia, pain, sleep disorder, Parkinson's disease dementia, dementia with Lewy bodies and the like. The present invention relates to a compound represented by the formula (I) or a salt thereof: wherein each symbol is as defined in the attached DESCRIPTION.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/